These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 30689121)

  • 21. Efficacy and safety of bortezomib in patients with plasma cell leukemia.
    Musto P; Rossini F; Gay F; Pitini V; Guglielmelli T; D'Arena G; Ferrara F; Filardi N; Guariglia R; Palumbo A; ; ;
    Cancer; 2007 Jun; 109(11):2285-90. PubMed ID: 17469169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study.
    Guan J; Ma J; Chen B
    Hematology; 2023 Dec; 28(1):2254556. PubMed ID: 37732631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A primitive plasma cell leukemia with immunoglobulin (Ig) E].
    Rachidi M; Lazarian G; Letestu R; Lusina D; Desbene C; Vidal V; Eclache V; Baran-Marszak F; Cymbalista F; Fleury C
    Ann Biol Clin (Paris); 2019 Oct; 77(5):557-561. PubMed ID: 31512579
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revised diagnostic criteria for plasma cell leukemia: results of a Mayo Clinic study with comparison of outcomes to multiple myeloma.
    Ravi P; Kumar SK; Roeker L; Gonsalves W; Buadi F; Lacy MQ; Go RS; Dispenzieri A; Kapoor P; Lust JA; Dingli D; Lin Y; Russell SJ; Leung N; Gertz MA; Kyle RA; Bergsagel PL; Rajkumar SV
    Blood Cancer J; 2018 Nov; 8(12):116. PubMed ID: 30442928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic impact of circulating plasma cells in patients with multiple myeloma: implications for plasma cell leukemia definition.
    Granell M; Calvo X; Garcia-Guiñón A; Escoda L; Abella E; Martínez CM; Teixidó M; Gimenez MT; Senín A; Sanz P; Campoy D; Vicent A; Arenillas L; Rosiñol L; Sierra J; Bladé J; de Larrea CF;
    Haematologica; 2017 Jun; 102(6):1099-1104. PubMed ID: 28255016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Plasma cell leukemia: three case-reports and review of literature].
    Eddou H; Mahtat el M; Zahid H; Maaroufi HE; Jennane S; Messaoudi N; Doghmi K; Mikdame M
    Ann Biol Clin (Paris); 2013; 71(6):698-702. PubMed ID: 24342791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma cell leukemia.
    Hayman SR; Fonseca R
    Curr Treat Options Oncol; 2001 Jun; 2(3):205-16. PubMed ID: 12057120
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Plasma cell leukemia].
    Egli F; Rhyner K
    Schweiz Rundsch Med Prax; 1989 Jan; 78(3):29-34. PubMed ID: 2919252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome.
    Todoerti K; Agnelli L; Fabris S; Lionetti M; Tuana G; Mosca L; Lombardi L; Grieco V; Bianchino G; D'Auria F; Statuto T; Mazzoccoli C; De Luca L; Petrucci MT; Morabito F; Offidani M; Di Raimondo F; Falcone A; Omede' P; Tassone P; Boccadoro M; Palumbo A; Neri A; Musto P
    Clin Cancer Res; 2013 Jun; 19(12):3247-58. PubMed ID: 23599371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Characteristics and Outcomes of Patients With Primary Plasma Cell Leukemia in the Era of Novel Agent Therapy.
    Nandakumar B; Kumar SK; Dispenzieri A; Buadi FK; Dingli D; Lacy MQ; Hayman SR; Kapoor P; Leung N; Fonder A; Hobbs M; Hwa YL; Muchtar E; Warsame R; Kourelis TV; Russell S; Lust JA; Lin Y; Siddiqui M; Go RS; Jevremovic D; Kyle RA; Gertz MA; Rajkumar SV; Gonsalves WI
    Mayo Clin Proc; 2021 Mar; 96(3):677-687. PubMed ID: 33673918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current Status on Management of Primary Plasma Cell Leukemia.
    Gong Z; Khosla M; Vasudevan S; Mohan M
    Curr Oncol Rep; 2024 Sep; 26(9):1104-1112. PubMed ID: 38954316
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IgM Myeloma with Plasma Cell Leukemia: Case Report and Literature Review.
    Chhabra S; Jain S; Fowler A; Sedov V; Neppalli AK; Schandl CA; Lazarchick J
    Ann Clin Lab Sci; 2017 Sep; 47(5):611-619. PubMed ID: 29066491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bortezomib, Doxorubicin, Cyclophosphamide, Dexamethasone Induction Followed by Stem Cell Transplantation for Primary Plasma Cell Leukemia: A Prospective Phase II Study of the Intergroupe Francophone du Myélome.
    Royer B; Minvielle S; Diouf M; Roussel M; Karlin L; Hulin C; Arnulf B; Macro M; Cailleres S; Brion A; Brechignac S; Belhadj K; Chretien ML; Wetterwald M; Chaleteix C; Tiab M; Leleu X; Frenzel L; Garderet L; Choquet S; Fuzibet JG; Dauriac C; Forneker LM; Benboubker L; Facon T; Moreau P; Avet-Loiseau H; Marolleau JP
    J Clin Oncol; 2016 Jun; 34(18):2125-32. PubMed ID: 27114594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two cases of nonsecretory multiple myeloma presenting as primary plasma cell leukemia.
    Takahashi T; Kanno S; Itoh H; Yoshimoto M; Tsujisaki M; Fujino M
    Intern Med; 2014; 53(18):2121-5. PubMed ID: 25224200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical Characteristics and Survival Analysis of Patients with Plasma Cell Leukemia].
    Wang SF; Qin XQ; Guo QH; Wang JY; Ma YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Jun; 31(3):693-698. PubMed ID: 37356928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma cell leukemia and hyperviscosity syndrome.
    Geraci JM; Hansen RM; Kueck BD
    South Med J; 1990 Jul; 83(7):800-5. PubMed ID: 2196691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma cell leukemia maintaining complete remission by syngeneic stem cell transplantation combined with low-dose thalidomide maintenance therapy.
    Abe M; Yokoyama H; Tohmiya Y; Okitsu Y; Ohguchi H; Kohata K; Yamamoto J; Onishi Y; Ishizawa K; Kameoka J; Harigae H
    Intern Med; 2009; 48(20):1833-5. PubMed ID: 19834277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical characteristics and prognosis of patients with primary plasma cell leukemia (pPCL) according to the new IMWG definition criteria.
    Yan W; Fan H; Xu J; Liu J; Li L; Du C; Deng S; Sui W; Hao M; Yi S; Zou D; Qiu L; Xu Y; An G
    Leuk Lymphoma; 2022 Dec; 63(12):2955-2964. PubMed ID: 35819882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary plasma cell leukemia in Latin America: demographic, clinical, and prognostic characteristics. A study of GELAMM group.
    Peña C; Riva E; Schutz N; Ramírez A; Vásquez J; Del Carpio D; Seehaus C; Ochoa P; Vengoa R; Duarte P; Martínez-Cordero H; Figueredo Y; Ríos RO; Ramírez J; Bove V; Roa M; Russo M; Espinoza M; Rodriguez G; Remaggi G; Enciso ME; Chandía M; Fantl D;
    Leuk Lymphoma; 2023 Apr; 64(4):816-821. PubMed ID: 36695519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-risk Multiple Myeloma: Definition and Management.
    Joseph NS; Gentili S; Kaufman JL; Lonial S; Nooka AK
    Clin Lymphoma Myeloma Leuk; 2017 Jul; 17S():S80-S87. PubMed ID: 28760306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.